Related Experiment Video
Updated: Jun 25, 2026

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
Published on: February 10, 2013
Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical
D Scrutinio1, V Napoli, A Passantino
1Division of Cardiology, "Salvatore Maugeri" Foundation, IRCCS, Rehabilitation Institute of Cassano Murge, Bari, Italy.
Insights
Low-dose dobutamine echocardiography effectively assesses myocardial contractile reserve in chronic heart failure patients. The cardiac response correlates with peak exercise oxygen consumption (VO2), predicting disease severity and clinical outcomes.
Area of Science:
- Cardiology
- Heart Failure Research
- Diagnostic Imaging
Background:
- Idiopathic dilated cardiomyopathy (IDC) causes chronic heart failure (CHF).
- Assessing myocardial contractile reserve is crucial for stratifying CHF severity.
- Peak exercise oxygen consumption (VO2) is a key indicator of CHF prognosis.
Purpose of the Study:
- To evaluate myocardial contractile reserve in CHF patients with IDC using low-dose dobutamine echocardiography.
- To correlate echocardiographic findings with peak exercise oxygen consumption (VO2) for disease stratification.
- To assess the predictive value of dobutamine response for clinical outcomes.
Main Methods:
- Sixty CHF patients with IDC underwent cardiopulmonary exercise testing and low-dose dobutamine echocardiography.
- Echocardiographic parameters (end-systolic volume index, ejection fraction, cardiac output) were measured at baseline and peak dobutamine dose.
- Patients were stratified by Weber classification based on peak VO2; results were compared to a control group.
Main Results:
- CHF patients showed significantly lower echocardiographic variables compared to controls.
- A significant decrease in the percentage change of end-systolic volume index, ejection fraction, and cardiac output was observed from Weber class A to C.
- The percentage change in end-systolic volume index was significantly associated with peak VO2 < 15 ml/kg/min and adverse clinical events.
Conclusions:
- Low-dose dobutamine echocardiography is a valuable tool for assessing myocardial contractile reserve in IDC-related CHF.
- The cardiac response to dobutamine is correlated with peak VO2, reflecting disease severity.
- Echocardiographic assessment of dobutamine response predicts clinical outcomes in these patients.
Aims:
To evaluate myocardial contractile reserve using low-dose dobutamine echocardiography in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy stratified by peak exercise oxygen consumption (VO(2)).
Methods And Results:
Sixty clinically stable patients (56+/-11 years; 45 males) with idiopathic cardiomyopathy and NYHA class I to III symptoms of heart failure were studied and followed-up for 13+/-3 months. All patients underwent cardiopulmonary exercise testing and low-dose dobutamine. The dobutamine infusion protocol consisted of an initial dose of 2.5 micro. kg(-1)per 3 min, increasing by 2.5 micro. kg(-1)per min every 3 min; the maximal dose was 10 micro. kg(-1)per min. The end-systolic volume index, left ventricular ejection fraction and cardiac output were measured at baseline and peak dobutamine dose and their change calculated as ((peak dose value-baseline value)/baseline value]x100. Ten normal subjects with normal left ventricular function and no coronary artery lesions served as a control group to compare low-dose dobutamine results. All analysed echocardiographic variables either at baseline or following dobutamine infusion were significantly lower in patients with chronic heart failure as a whole compared to the control group. When the patients were grouped according to Weber's classification, a statistically significant decrease in percentange changes in end-systolic volume index (rho=-0.77;P<0.0001), left ventricular ejection fraction (rho=-0.72;P<0.0001) and cardiac output (rho=-0. 82;P<0.0001) from class A to class C was observed. The mean percentage decrease in end-systolic volume index following the dobutamine infusion was 28.7+/-9% in class A (peak VO(2)>20 ml. kg(-1). min(-1)), 18.6+/-8% in class B (peak VO(2)between 16 and 20 ml. kg. min(-1)), and only 6.4+/-6% in class C (peak VO(2)between 10 and 16 ml. kg(-1). min(-1)) patient groups. At multivariate analysis, only the percentage change in end-systolic volume index was significantly associated with a peak VO(2)<15 ml. kg(-1). min(-1)(P=0.006). During the follow-up, 17 patients had events (15 readmissions for worsening heart failure and two deaths). At multivariate analysis, only the percentage change in end-systolic volume index was significantly associated with the occurrence of events (P=0.003). The area under the receiver operating characteristic curve for percentage change in end-systolic volume index was not significantly different from that for peak VO(2)(0. 86+/-0.04 vs 0.80+/-0.06;P:ns).
Conclusion:
This study indicates that in patients with chronic heart failure secondary to idiopathic cardiomyopathy, the cardiac response to low-dose dobutamine, as assessed by echocardiography, is correlated with peak VO(2), an objective and accurate measure of the severity of the disease and clinical outcome.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: β-Blockers
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

